佳醫 (4104)
佳醫 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$960.23M, up 24.5% from a year earlier. EPS over the last four quarters totals NT$4.87.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2007-12-31
- Founded
- 1988-03-15
- Paid-in capital
- NT$1.88B
- Common shares issued
- 188,367,456
- Legal name
- 佳醫健康事業股份有限公司
- Website
- https://www.excelsiormedical.com.tw
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$960.23M | +1.7% | +24.5% |
| 2026-08 | NT$944.35M | +12.0% | +32.2% |
Year to date: +14.8% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 1.65 |
| 2026 Q1 | 1.12 |
| 2025 Q4 | 1.13 |
| 2025 Q3 | 0.97 |
| 2025 Q2 | 1.41 |
| 2025 Q1 | 1.19 |
| 2024 Q4 | 1.18 |
| 2024 Q3 | 0.93 |
Last four quarters: NT$4.87
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 4.30 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 25,812 | 1.1% |
| 1,000–5,000 shares | 13,977 | 15.2% |
| 5,001–10,000 shares | 2,263 | 8.5% |
| 10,001–15,000 shares | 827 | 5.4% |
| 15,001–20,000 shares | 335 | 3.1% |
| 20,001–30,000 shares | 331 | 4.3% |
| 30,001–40,000 shares | 130 | 2.4% |
| 40,001–50,000 shares | 69 | 1.6% |
| 50,001–100,000 shares | 136 | 4.9% |
| 100,001–200,000 shares | 55 | 4.0% |
| 200,001–400,000 shares | 26 | 4.0% |
| 400,001–600,000 shares | 10 | 2.6% |
| 600,001–800,000 shares | 5 | 1.8% |
| 800,001–1,000,000 shares | 2 | 0.9% |
| 1,000,001+ shares | 8 | 40.1% |
TDCC data for 2026-10-16: 8 holders own more than 1,000 lots (40.1% of shares), and 25,812 hold less than one lot (1.1%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -28 | 0 | -4 | -32 |
| 2026-10-16 | 21 | 0 | -6 | 15 |
| 2026-10-15 | 185 | 0 | -5 | 180 |
| 2026-10-14 | 34 | 0 | 11 | 45 |
| 2026-10-13 | 55 | 0 | -2 | 53 |
| 2026-10-12 | 74 | 0 | 0 | 74 |
| 2026-10-08 | 34 | 0 | 0 | 34 |
| 2026-10-07 | 29 | 0 | 0 | 29 |
| 2026-10-06 | -45 | 0 | 3 | -42 |
| 2026-10-05 | -19 | 0 | 1 | -18 |
| 2026-10-02 | 15 | 0 | 0 | 15 |
| 2026-10-01 | 7 | 0 | 6 | 13 |
| 2026-09-30 | 75 | 0 | 29 | 104 |
| 2026-09-29 | 18 | 0 | 1 | 19 |
| 2026-09-24 | 3 | 0 | 0 | 3 |
| 2026-09-23 | 16 | 0 | 0 | 16 |
| 2026-09-22 | 0 | 0 | 0 | 0 |
| 2026-09-21 | -32 | 0 | 2 | -30 |
| 2026-09-18 | 35 | 0 | 3 | 38 |
| 2026-09-17 | 61 | 0 | 1 | 62 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 578 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$73.60 (2026-10-19); 52-week range NT$67.30–85.60.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.